PRELUDE CAPITAL MANAGEMENT, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 156 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2023$220,870
-12.7%
4,788
-21.8%
0.01%
+55.6%
Q3 2022$253,000
+9.1%
6,119
+121.8%
0.01%
+50.0%
Q4 2021$232,000
-37.1%
2,759
-28.7%
0.01%
-45.5%
Q2 2021$369,000
+63.3%
3,869
+94.9%
0.01%
+83.3%
Q1 2021$226,000
+247.7%
1,985
+150.0%
0.01%
+100.0%
Q3 2020$65,000
-90.0%
794
-90.5%
0.00%
-91.7%
Q2 2020$651,000
+425.0%
8,322
+197.2%
0.04%
+350.0%
Q1 2020$124,000
+1277.8%
2,800
+2070.5%
0.01%
+700.0%
Q1 2019$9,000
-98.2%
129
-98.4%
0.00%
-97.9%
Q2 2017$497,000
+163.0%
8,000
+167.3%
0.05%
+80.8%
Q1 2016$189,0002,9930.03%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2017
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders